Webinar presenter Karen Raraigh, MGC, CGCD, Assistant Professor of Genetic Medicine at Johns Hopkins University, discusses how expanded genetic testing is playing an increasingly vital role in the management of Cystic Fibrosis (CF), helping to elevate the standard of care. With recent technological advancements, updated clinical guidelines, and a growing disease variant database, healthcare professionals are now better equipped to:
• Broaden access to CF care and reduce the burden on families
• Enhance accuracy in interpreting CFTR gene variants in clinical practice
This on-demand webinar was originally broadcast on June 11, 2025.
What will you learn from this webinar?
• Explore how updates to the CFTR2 database and variant list can support clinical decision-making.
• Learn about new recommendations for newborn screening programs aimed at improving timeliness, sensitivity, and equity in CF diagnosis.
• Gain insights into the ACMG workgroup’s guidance for minimizing bias and promoting consistency in CF carrier screening.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Devyser.